The Annual Meeting is an extraordinary venue that fosters scientific discussions and helps build bridges across various disciplines. We encourage all CIMM members to take advantage of the opportunities presented at the meeting to learn about the latest breakthroughs in cancer immunology, attend sessions outside your own areas of expertise and network with other scientists and clinicians interested in cancer immunology and immunotherapy.
The AACR 102nd Annual Meeting 2011 was held April 2 - 6, 2011, in Orlando, FL.
CIMM hosted a variety of sessions and events at the Annual Meeting:
Educational Session: Tumor Immunology for the Non-Immunologist
In conjunction with the Cancer Immunology Working Group
Saturday, April 2, 2011
8:00 a.m. - 10:00 a.m.
Orange County Convention Center, West Hall F1/F2
Chairperson: Thomas F. Gajewski, University of Chicago, Chicago, IL
Cancer is a product of genetic mutations and errors in epigenetic regulation. However, the potential of these malignant changes to cause disease is significantly regulated by the host immune system. In this session, the major interactions between the immune system and cancer were reviewed, those that result in cancer prevention as well as those that result in cancer progression. Also discussed was how this knowledge is applied to cancer immunotherapy currently practiced in the clinic. Immediately following the formal session, members of the Cancer Immunology Working Group provided additional one-on-one tutorials for participants who were interested in learning more.
Cancer Immunology for the Non-Immunologist -- Tutorial
In conjunction with the Cancer Immunology Working Group
Saturday, April 2, 2011
10:00 a.m. - 12:00 p.m.
Orange County Convention Center, W222
The Cancer Immunology Working Group (CIMM) offered roundtable tutorials for attendees seeking information or advice on immunological topics and approaches related to their work. CIMM members were at pre-assigned tables ready to promote dialogue and respond to questions from interested investigators. This session immediately followed the Tumor Immunology for Non-Immunologists Educational Session that was held at the Orange County Convention Center, West Hall F1/F2. The participants in that session as well as all other meeting attendees with immunology-based questions were encouraged to attend.
Faculty: Thomas F. Gajewski, Pedro J. Romero, Nicholas P. Restifo and Weiping Zou
Additional faculty to be announced.
CIMM Town Meeting and Reception
Sunday, April 3, 2011
6:00 - 7:30 p.m.
The Peabody Hotel, Peabody Q
All interested 2011 Annual Meeting registrants were invited to attend CIMM's Fourth Annual Town Meeting and Reception. The Town Meeting provided an opportunity for attendees to learn about the Working Group, meet the members of the Steering Committee, connect with old colleagues and meet new ones, and contribute ideas to help shape future CIMM initiatives. Dr. Olivera J. Finn, CIMM Steering Committee Chairperson, discussed new events and initiatives being planned for the Working Group. Additionally, an update on the Cancer Immunotherapy Trials Network (CITN) was given by Martin Cheever, M.D., The Fred Hutchinson Cancer Center, Seattle, WA, and there were two presentations on immune modifiers pathways funded through the Special Translational Research Acceleration Program (STRAP). Andrew A. Raubitschek, M.D., City of Hope; Duarte, CA, presented “Taking iRGD Through the Valley of Death” and Michel Sadelain, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center; New York, NY presented “Engineered T Cells Go Multi-Center.”
TME-CIMM Joint Evening Scientific Session
“The Tumor Microenvironment and the Immune Response”
Tuesday, April 5, 2011
6:30-8:30 p.m.
Orange County Convention Center, W208.
CIMM Members and all other interested Annual Meeting registrants were encouraged to attend this exciting jointly-sponsored working group event.
Chairpersons:
Yves A. DeClerck, M.D., USC and the Children’s Hospital Los Angeles, Los Angeles, CA
Louis M. Weiner, M.D., Georgetown Lombardi Cancer Center, Washington, DC
This exciting joint evening session focused on the intersection of the tumor microenvironment and the immune response to it. The program included the following talks: Stromal-epithelial Interactions during Early Carcinogenesis; Fibroblast Activation Protein (FAP) and its Role in the Tumor Microenvironment; and The Ying and Yang of the Immune System in Cancer Progression. The program was followed by a panel discussion including the speakers and chairpersons.
Speakers include:
Thea D. Tlsty, Ph.D., UCSF School of Medicine, San Francisco, CA
Ellen Pure´, Ph.D., The Wistar Institute, Philadelphia, PA
Robert C. Seeger, M.D., USC/Children’s Hospital of Los Angeles, Los Angeles, CA
Other Immunology-Focused Sessions:
Educational Session: Molecular Mechanisms Regulating Tumor Immune Escape: Journey from Bench to Bedside
Saturday, April 2, 2011
10:15 a.m. -12:15 p.m.
Orange County Convention Center, W311 A-D
Education Session: The Role of Innate Immune Receptors in Cancer
Saturday, April 2, 2011
1:00 p.m. - 3:00 p.m
Orange County Convention Center, W224 A/B/E/F
Forum: What Kind of T-Cell is best for Adoptive Immunotherapy?
Tuesday, April 5, 2011
5:00 p.m. - 6:30 p.m.
Orange County Convention Center, W415 B/C (Valencia Ballroom)
Symposia: Cancer Vaccines for Cancer Prevention
Tuesday, April 5, 2011
1:00 p.m. - 3:00 p.m.
Orange County Convention Center, West Hall F1/F2
Symposia: Immune Checkpoint Blockade: New Insights and Opportunities
Tuesday, April 5, 2011
10:30 a.m. - 12:30 p.m.
Orange County Convention Center, W415 B/C (Valencia Ballroom)
Symposia: Tumor Vasculature and Stroma Control Leukocyte Trafficking, Tumor Infiltration and Function
Wednesday, April 6, 2011
11:00 a.m. - 1:00 p.m.
Orange County Convention Center, West Hall F1/F2
Minisymposia: Poised for the Clinic: the Next Generation of Cancer Immunotherapy
Sunday, April 3, 2011
3:15 p.m. - 5:15 p.m.
Orange County Convention Center, W224 A/B/E/F
Minisymposia: Mouse Models of Inflammation-associated Cancers
Tuesday, April 5, 2011
3:00 p.m. - 5:00 p.m.
Orange County Convention Center, W224 A/B/E/F
Immunotherapies: Immune Modulation/Adoptive Immunotherapy
Monday, April 4, 2011
10:30 a.m. - 12:30 p.m.
Orange County Convention Center, W224 C/D/G/H
Prostate Cancer Immunotherapy: Initial Successes and Next Steps
Sunday, April 3, 2011
1:00 p.m. - 3:00 p.m.
Orange County Convention Center, W224 C/D/G/H
Immunogenic Cancer Cell Death for Optimal Chemotherapy
Saturday, April 2, 2011
3:15 p.m. - 4:15 p.m.
Orange County Convention Center, West Hall F1/F2
Aspects of the Tumor-immune Microenvironment that Regulate Cancer Development
Saturday, April 2, 2011
4:30 p.m. – 5:30 p.m.
Orange County Convention Center, West Hall F5